Habituation, discrimination and anxiety in transgenic mice overexpressing acetylcholinesterase splice variants

Brain Research

Volumn 1185, Issue 1, 2007, Pages 170-178

  Kofman, Ora ^a   Shavit, Yehoshua ^a   Ashkenazi, Sarit ^a   Gabay, Shai ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acetylcholinesterase; Discrimination learning; Elevated plus maze; Locomotor activity; Transgenic

Indexed keywords

ACETYLCHOLINESTERASE; CYSTEINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DISCRIMINATION LEARNING; ELEVATED PLUS MAZE TEST; GENE DISRUPTION; GENOTYPE; HABITUATION; LOCOMOTION; MAZE TEST; MOUSE; MOUSE STRAIN; NONHUMAN; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TRANSGENIC MOUSE;

ACETYLCHOLINESTERASE; ANIMALS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CYSTEINE; DISCRIMINATION (PSYCHOLOGY); FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; ODORS; PROTEIN ISOFORMS; RISK ASSESSMENT; SEX FACTORS; TIME FACTORS;

MUS; MUS MUSCULUS;

EID: 36448978846     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.09.018     Document Type: Article

References (47)

1. Acquas E., Wilson C., and Fibiger H.C. Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation and fear. J. Neurosci. 16 (1996) 3089-3096
2. Aldridge J.E., Levin E.D., Seidler F.J., and Slotkin T.A. Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression. Environ. Health Perspect. 113 (2005) 527-531
3. Balducci C., Nurra M., Peitropoli A., Samanin R., and Carli M. Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonis WAY 100635. Psychopharmacology 67 (2003) 28-36
4. Beeri R., Andres C., Lev-Lehman E., Timberg R., Huberman T., Shani M., and Soreq H. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5 (1995) 1063-1071
5. Beeri R., Le Novere N., Mervis R., Huberman T., Grauer E., Changeux J.P., and Soreq H. Enhanced hemicholinium binding and attenuated dendritic branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69 (1997) 2441-2451
6. Birikh K.R., Sklan E.H., Shoham S., and Soreq H. Interaction of "readthrough" acetylcholinesterase with RACK1 and PKC II correlates with intensified fear-induced conflict behavior. Proc. Natl. Acad. Sci. 100 (2003) 283-288
7. Broide R.S., Grifman M., Loewenstein A., Grisaru D., Timberg R., Stone J., Shani M., Patrick J.W., and Soreq H. Manipulations of AChE gene expression suggest non-catalytic involvement of acetylcholinesterase in the functioning of mammalian photoreceptors but not in retinal degeneration. Mol. Brain Res. 71 (1999) 137-148
8. Ceccarrelli I., Casamenti F., Massafra C., Pepeu G., Scali C., and Aloisi A.M. Effects of novelty and pain on behavior and hippocampal ACh levels in male and female rats. Brain Res. 815 (1999) 169-176
9. Cohen O., Erb C., Ginzberg D., Seidman Y., Shoham S., Yirmiya S., and Soreq R. Neuronal overexpression of 'readthrough' acetylcholinesterase is associated with antisense-suppressible behavioral impairments. Mol. Psychiatry 7 (2002) 874-885
10. Cohen O., Reichenberg A., Perry C., Ginzburg D., Pollmacher T., Soreq H., and Yirmiya R. Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase. J. Mol. Neurosci. 21 (2003) 195-208
11. Davidson M.C., Cutrell E.B., and Marrocco R.T. Scopolamine slows the orienting of attention in primates to cued visual targets. Psychopharmacology 142 (1999) 1-8
12. Day T., and Greenfield S.A. A non-cholinergic, trophic action of acetylcholinesterase on hippocampal neurones in vitro: molecular mechanisms. Neuroscience 111 (2002) 649-656
13. Dori A., Cohen J., Silverman W.F., Pollack Y., and Soreq H. Functional manipulations of acetylcholinesterase splice variants highlight alternative splicing contributions to murine neocortical development. Cereb. Cortex 15 (2005) 419-430
14. Erb C., Troost J., Kopf S., Schmitt U., Löffelholz K., Soreq H., and Klein J. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J. Neurochem. 77 (2001) 638-646
15. Espejo E.F. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behav. Brain Res. 87 (1997) 233-238
16. Everitt B.J., and Robbins T.W. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48 (1997) 649-684
17. Farchi N., Shoham S., Hochner B., and Soreq H. Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection. Eur. J. Neurosci. 25 (2007) 87-98
18. File S.E., Gonzalez L.E., and Andrews N. Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic receptors. Behav. Neurosci. 112 (1998) 353-359
19. Fine A., Hoyle C., Maclean C.J., Levatte T.L., Baker H.F., and Ridley R.M. Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys. Neuroscience 81 (1997) 331-343
20. Freo U., Ricciardi E., Pietrini P., Schapiro M.B., Rapoport S.I., and Furey M.L. Pharmacological modulation of prefrontal cortical activity during a working memory task in young and older humans: a PET study with physostigmine. Am. J. Psychiatry 162 (2005) 2061-2070
21. Furey M.L., Pietrini P., and Haxby J.V. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290 (2000) 2315-2319
22. Grisaru D., Pick M., Perry C., Sklan E.H., Almog R., Goldberg I., Naparstek E., Lessing J.B., Soreq H., and Deutsch V. Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses. J. Immunol. 176 (2006) 27-35
23. Humby T., Laird F.M., Davies W., and Wilkinson L.S. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur. J. Neurosci. 11 (1999) 2813-2823
24. Kaufer D., Friedman A., Seidman S., and Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393 (1998) 373-377
25. Keymer J.E., Gaete J., Kameid G., and Alvarez J. Acetylcholinesterase and inhibitors: effects upon normal and regenerating nerves of the rat. Eur. J. Neurosci. 11 (1999) 1049-1057
26. Kofman O., and Ben-Bashat G. Diisopropylfluorophosphate administration in the pre-weanling period induces long-term changes in anxiety behavior and passive avoidance in adult mice. Psychopharmacology 183 (2006) 452-461
27. Levin E.D., Nii A., Nakajima A., Christopher C., Seidler F.J., and Slotkin T.A. Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Dev. Brain Res. 130 (2001) 83-89
28. MacDonald S.H.-F., Ruth P., Knaus H.-G., and Shipston M.J. Increased large conductance calcium-activated potassium (BK) channel expression accompanied by STREX variant downregulation in the developing mouse CNS. BMC Dev. Biol. 6 37 (2006) 10.1186/1471-213X-6-37
29. McCobb D.P., Hara Y., Lai G.-J., Mahmoud S.F., and Flügge G. Subordination stress alters alternative splicing of the Slo gene in tree shrew adrenals. Horm. Behav. 43 (2006) 180-186
30. Meshorer E., Erb C., Gazit R., Pavlovsky L., Kaufer D., Friedman A., Glick D., Ben-Arie N., and Soreq H. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295 (2002) 508-512
31. Meshorer E., and Soreq H. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci. 29 (2006) 216-222
32. Mesulam M.M. Structure and function of cholinergic pathways in the cerebral cortex, limbic system, basal ganglia, and thalamus of the human brain. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1994), Raven Press, New York 135-146
33. Muggleton N.G., Bowditch A.P., Crofts H.S., Scott A.M., and Pearce P.C. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioral effects of organophosphates in the common marmoset (Callithrix jacchus). Psychopharmacology 166 (2003) 212-220
34. Nijholt I., Farchi N., Kye M., Sklan E.H., Shoham S., Verbeure B., Owen D., Hochner B., Spiess J., Soreq H., and Blank T. Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Mol. Psychiatry 9 (2004) 174-183
35. Rodgers R.J., and Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci. Biobehav. Rev. 21 (1997) 801-810
36. Perrier N.A., Salani M., Falasca C., Bon S., Augusti-Tocco S., and Massoulie J. The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo. J. Neurochem. 94 (2005) 629-638
37. Pritchard L.M., Logue A.D., Taylor B.C., Ahlbrand R., Welge J.A., Tang Y., Sharp F.R., and Richtand N.M. Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty. Brain Res. Bull. 70 (2006) 296-303
38. Sarter M., and Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Rev. 23 (1997) 28-46
39. Shohami E., Kaufer D., Chen Y., Seidman S., Cohen O., and Ginzberg D. Antisense prevention of neuronal damages following head injury in mice. J. Mol. Med. 78 (2000) 228-236
40. Sklan E., Lowenthal A., Korner M., Ritov Y., Landers D.M., Rankinen T., Bouchard C., Leon A.S., Rice T., Rao D.C., Wilmore J.H., Skinner J.S., and Soreq H. Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study. Proc. Natl. Acad. Sci. 101 (2004) 5512-5517
41. Sklan E., Podoly E., and Soreq H. RACK1 has the nerve to act: structure meets function in the nervous system. Prog. Neurobiol. 78 (2006) 117-134
42. Soreq H., and Seidman S. Acetylcholinesterase-new roles for an old actor. Nat. Rev. Neurosci. 2 (2001) 294-302
43. StatSoft, Inc. STATISTICA (data analysis software system), version 7.0 (2004). http://www.statsoft.com www.statsoft.com
44. Sternfeld M., Shoham S., Klein O., Flores-Flores C., Evron T., Idelson G.H., Kitsberg D., Patrick J.W., and Soreq H. Excess "read-through" aceytylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc. Natl. Acad. Sci. 97 (2000) 8647-8652
45. Tinkler G.P., and Voyko M.L. Estrogen modulates cognitive and cholinergic processes in surgically menopausal monkeys. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 29 (2005) 423-431
46. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., and Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9 (2006) 519-525
47. Zhu W., Umegai H., Suzuki Y., Miura H., and Iguchi A. Involvement of the bed nucleus of the stria terminalis in hippocampal cholinergic system-mediated activation of the hypothalamic-pitiuitary-adrenocortical axis in rats. Brain Res. 916 (2001) 101-106